ESC 365 - Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials

ESC Premium Access

Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials

Session: Evolving frontiers for coronary artery disease

Topic: Pharmacotherapy

Speaker: Professor W. Koenig (Munich, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

1 more presentation in this session

A view to the future: approach to vulnerable plaque and/or vulnerable patients

Speaker: Professor R. Byrne (Dublin, IE)

Access the full session

Evolving frontiers for coronary artery disease

Speakers: Professor W. Koenig, Professor R. Byrne

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by